Sofosbuvir [sofosbuvir]
- Terms
-
Harvoni
Sovaldi
-
2-((5-(2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-4-fluoro-3-hydroxy-4-methyltetrahydrofuran-2-ylmethoxy)phenoxyphosphorylamino)propionic acid isopropyl ester
GS-7977
PSI 7977
PSI-7977
PSI7977
Sovaldi
A uridine monophosphate analog inhibitor of HEPATITIS C VIRUS (HCV) polymerase NS5B that is used as an ANTIVIRAL AGENT in the treatment of CHRONIC HEPATITIS C.
- DUI
- D000069474 MeSH Browser
- CUI
- M0551450
- History note
- 2016 (2010)
- Public note
- 2016; SOFOSBUVIR was indexed under URIDINE MONOPHOSPHATE 2010-2015
Allowable subheadings
- AD
- administration & dosage 7
- AE
- adverse effects 5
- AG
- agonists
- AA
- analogs & derivatives
- AN
- analysis
- AI
- antagonists & inhibitors
- BL
- blood
- CF
- cerebrospinal fluid
- CS
- chemical synthesis
- CH
- chemistry
- CL
- classification
- EC
- economics 1
- HI
- history
- IM
- immunology
- IP
- isolation & purification
- ME
- metabolism
- PK
- pharmacokinetics 5
- PD
- pharmacology 16
- PO
- poisoning
- RE
- radiation effects
- ST
- standards
- SD
- supply & distribution
- TU
- therapeutic use 31
- TO
- toxicity
- UR
- urine
ledipasvir, sofosbuvir drug combination Chemical MeSH Browser
sofosbuvir velpatasvir voxilaprevir drug combination Chemical MeSH Browser
sofosbuvir-velpatasvir drug combination Chemical MeSH Browser